Lamotrigine is primarily used in mental health as a mood stabilizer for bipolar disorder. Its FDA-approved psychiatric use is specifically for maintenance treatment of bipolar I disorder, where it helps delay the return of mood episodes, including depression, mania, hypomania, and mixed states. Unlike many psychiatric medications that target acute crises, lamotrigine’s main role is long-term prevention.
Its Role in Bipolar Disorder
Lamotrigine is approved for maintenance treatment of bipolar I disorder after a patient has already been stabilized from an acute mood episode with other therapies. The goal is to keep mood episodes from coming back. This is an important distinction: lamotrigine is not recommended for treating acute manic or mixed episodes, and its effectiveness during active mood episodes has not been established by the FDA.
Where lamotrigine stands out compared to other mood stabilizers is its relative strength against depressive episodes. Lithium, the other major mood stabilizer, is better at preventing mania. A Cochrane review comparing the two found that people taking lamotrigine had roughly twice the rate of manic relapse compared to those on lithium, but the two drugs performed similarly for overall mood stability. In practice, this means lamotrigine is often the preferred choice when depressive episodes are the bigger concern, while lithium may be favored when mania is the primary risk.
Evidence for lamotrigine in bipolar II disorder is less clear. In the manufacturer’s registration trials, it did not outperform placebo for bipolar II depression, possibly because placebo response rates tend to be higher in that population. One later trial of 150 outpatients found it may help a specific subtype of bipolar II depression with more severe, “melancholic” features, but this hasn’t been confirmed broadly.
How It Works in the Brain
Lamotrigine was originally developed as an anti-seizure medication, and its mood-stabilizing effects stem from the same underlying mechanism. It interacts with voltage-gated channels in neurons, reducing excessive electrical firing. Rather than blocking all normal brain signaling, it selectively dampens abnormal bursts of activity. In lab studies, normal single nerve impulses were largely unaffected, while rapid, excessive firing triggered by stimulation was significantly suppressed.
This selective action also reduces the release of glutamate, the brain’s primary excitatory chemical messenger. Overactive glutamate signaling has been linked to mood instability, so by calming this system without broadly sedating the brain, lamotrigine stabilizes mood while generally leaving people feeling mentally clear. This is one reason patients often tolerate it well compared to other mood stabilizers that can cause cognitive dulling or significant sedation.
Off-Label Uses and What the Evidence Says
Lamotrigine is sometimes prescribed off-label for conditions beyond bipolar I disorder, but the evidence for these uses is weak or absent.
For unipolar depression (major depressive disorder without mania), lamotrigine has been tried both as a standalone treatment and as an add-on to antidepressants like SSRIs. Meta-analyses covering multiple randomized trials found no significant benefit over placebo in either approach. Despite its reputation for helping bipolar depression, the data does not support its use for standard depression.
It has also been explored for borderline personality disorder, particularly for symptoms like emotional instability and impulsivity. A systematic review and meta-analysis from Mayo Clinic researchers pooled the available randomized trials and found no consistent evidence that lamotrigine improved core BPD symptoms compared to placebo. The effect on impulsivity and aggression also failed to reach statistical significance.
Common Side Effects
Lamotrigine is generally considered one of the better-tolerated mood stabilizers. The most common side effects include dizziness, headache, double vision, and nausea. Many of these are dose-related and tend to be milder when the drug is started slowly.
The side effect that gets the most attention is a serious skin reaction called Stevens-Johnson syndrome, which can be life-threatening. This sounds alarming, but the actual incidence is low: about 2 in 10,000 adults and 4 in 10,000 children. A review of 22 randomized trials involving around 19,000 patients found that 8.3% experienced some kind of skin reaction, but only 0.04% developed Stevens-Johnson syndrome or its more severe form. The risk is closely tied to how quickly the dose is increased, which is why lamotrigine requires an unusually slow titration schedule.
The Slow Start-Up Schedule
Lamotrigine is started at a very low dose and increased gradually over several weeks. For bipolar disorder, the typical schedule begins at 25 mg per day for the first two weeks, then increases to 50 mg per day for another two weeks. After that, the dose is raised incrementally until reaching a maintenance dose, which is usually around 200 mg per day. This entire process takes at least five to six weeks.
This slow ramp-up can feel frustrating for patients who want relief quickly, but it exists specifically to minimize the risk of serious skin reactions. Rushing the titration is one of the most significant risk factors for developing a dangerous rash. If you miss doses for several days, your prescriber will likely have you restart the titration from the beginning for the same reason.
Hormonal Contraceptives and Dose Changes
One interaction that catches many patients off guard involves estrogen-based hormonal contraceptives. Birth control pills containing estrogen roughly double the rate at which the body clears lamotrigine, which can cut blood levels in half. This means that starting birth control could make lamotrigine less effective, and stopping it could cause levels to spike, increasing the risk of side effects.
Hormone replacement therapy can have a similar effect, with documented declines in lamotrigine levels of 25 to 50 percent. If you use any estrogen-containing hormonal therapy, your dose of lamotrigine will likely need to be adjusted, sometimes requiring up to twice the usual maintenance dose. The reverse is also true: if you stop taking hormonal contraceptives, your lamotrigine dose may need to come back down. This interaction applies specifically to estrogen-containing methods, not progestin-only options like certain IUDs or mini-pills.